DoW Orthopaedic, Applied Research Award

The Orthopaedic Research Program Applied Research Award is administered by the Defense Health Agency through the Congressionally Directed Medical Research Programs, a federal funding initiative established to support high-impact biomedical research aligned with military health priorities. The Orthopaedic Research Program was initiated by Congress to address the significant burden of musculoskeletal injuries among Service Members, particularly those sustained in combat or service-related activities. Over time, the program has funded hundreds of millions of dollars in research to improve recovery outcomes, restore function, and accelerate return to duty. This specific funding opportunity continues that mission by supporting applied research that translates existing knowledge into practical solutions for orthopaedic care. The primary purpose of the Applied Research Award is to fund research that advances treatment strategies and functional restoration for individuals with orthopaedic injuries. The program emphasizes applied research, defined as work that refines existing concepts into feasible solutions such as medical devices, therapeutic interventions, diagnostic techniques, or rehabilitation approaches. Projects must demonstrate clear pathways toward clinical translation and must be grounded in preliminary data. The program explicitly excludes basic research and clinical trials, focusing instead on preclinical studies that can bridge the gap between discovery and implementation. Research must also demonstrate relevance to military populations, although benefits to the broader public are expected. Funding under this opportunity is structured to support a limited number of high-impact projects. The program anticipates awarding approximately four grants, with each award capped at a total cost of 950000 dollars over a maximum performance period of three years. The total program funding is approximately 3800000 dollars. Funds may be used for direct and indirect research costs, including personnel, supplies, and required travel for dissemination of findings. However, costs related to clinical trials or non-exempt clinical research are not allowable. Applicants must also include travel funding for presenting results at a Department of Defense-sponsored meeting during the final year of the project. Eligibility for this opportunity is broad and inclusive. Both domestic and international organizations may apply, including for-profit and nonprofit entities, academic institutions, government agencies, and private organizations. Principal Investigators at all career stages are eligible, provided they are affiliated with an eligible organization. There are no restrictions based on citizenship or nationality. Importantly, cost sharing is not required, and awards are made to organizations rather than individuals. The program also encourages interdisciplinary collaborations, particularly those involving military, academic, and industry partners. The application process is conducted in two stages. First, applicants must submit a pre-application through the Electronic Biomedical Research Application Portal. This pre-application includes a concise narrative outlining the research problem, objectives, study design, and anticipated impact. Based on this submission, selected applicants are invited to submit a full application. The full application requires extensive documentation, including a detailed project narrative, technical and lay abstracts, statement of work, impact statement, transition plan, and supporting documentation such as letters of support and data management plans. Submission portals differ depending on applicant type, with extramural organizations submitting through Grants.gov and intramural organizations through eBRAP. Applications are evaluated through a two-tier review process consisting of peer review and programmatic review. Peer review assesses scientific merit, feasibility, impact, and methodological rigor, while programmatic review considers alignment with program priorities and portfolio balance. Evaluation criteria emphasize research strategy, potential impact on patient care, military relevance, and the strength of the transition plan. Applications must also demonstrate consideration of factors such as reproducibility, statistical rigor, and inclusion of sex as a biological variable. The timeline for this funding opportunity includes a pre-application deadline of August 19, 2026, followed by an invitation notification on September 25, 2026. Full applications are due November 18, 2026, with peer review expected in January 2027 and programmatic review in March 2027. Awards are anticipated to be made by September 30, 2027. The funding opportunity is issued annually as part of the Orthopaedic Research Program, indicating a recurring cycle. Applicants are encouraged to prepare early due to registration requirements and the complexity of the submission process. For assistance, applicants may contact the eBRAP Help Desk or the Grants.gov Support Center for technical guidance.

Strong preliminary data and clear transition-to-clinical-use pathways are critical; emphasize military relevance and return-to-duty impact; align closely with defined focus areas; demonstrate feasibility and translational potential